SELL YOUR PRODUCTS
*mymedicalexpo  
English

Rapid respiratory disease test VRI 10-plex
SARS-COV-2enterovirusadenovirus

rapid respiratory disease test
rapid respiratory disease test
Add to favorites
Compare this product
 

Characteristics

Applications
for respiratory diseases
Micro-organism
SARS-COV-2, enterovirus, adenovirus, coronavirus, influenza B, influenza A
Analysis mode
molecular

Description

The new Viral Respiratory Infection Array (VRI) will be conducted on Vivalytic, a point of care platform brought to the market by Randox Laboratories and Bosch. The Vivalytic system is a fully-automated, cartridge-based platform capable of both Hi-Plex and Lo-Plex testing. The VRI test can identify SARS-CoV-2 (COVID-19) and differentiate it from nine other respiratory infections with similar symptoms, including influenza and all known coronaviruses. Vivalytic cartridges are compact, technologically advanced Molecular Diagnostic tests utilising micro-fluidics to enable simple and accurate diagnostic testing. Randox patented Biochip Array Technology powers Vivalytic, enabling end-point qualitative PCR and providing multiple test results from each sample.

Catalogs

No catalogs are available for this product.

See all of Randox Laboratories‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.